Day 1: October 28, 2022 (Friday)
Plenary Forum (I)
Time: 09:10-12:10, October 28, 2022 (Friday); Place: Osaka, Japan
|
|
|
|
Dr. Yusuke Yamauchi, Professor, The University of Queensland, Australia |
|
|
09:10-09:40 |
Title: Multifunctional Synergy for Enhancing Materials Performance
Dr. Shi Xue Dou, Distinguished Professor, University of Wollongong, Australia |
|
|
09:40-10:10 |
Title: Functionalized Fluoride Materials for Photonics, Energy, and Sustainable Issues
Dr. Alain Tressaud, CNRS Emeritus Research Director, ICMCB, University Bordeaux, France, and Vice-President, European Academy of Sciences, Brussels, Belgium |
|
|
10:10-10:40 |
Title: New Strategies for Addressing the Issue of Waste Plastics
Dr. Yu-Zhong Wang, Professor, Sichuan University, China |
|
|
10:40-11:10 |
Title: Nanosciences, Biological Imaging and Renewable Energy
Dr. Hongjie Dai, Professor, Stanford University, USA |
|
|
11:10-11:40 |
Title: Carbon-based Nanomaterials for Various Applications
Dr. Michael Giersig, Professor, Free University of Berlin, Germany |
|
|
11:40-12:10 |
Title: The Nanomaterials Design and Processing for Electrodes of Metal Ion Batteries
Dr. Hua Kun Liu, Distinguished Professor, University of Wollongong, Australia |
|
|
Forum 4-1: Drug Discovery and Development
Time: 13:30-17:10, October 28, 2022 (Friday); Place: Osaka, Japan |
|
|
|
Dr. Wingfield Jonathan, Principal Scientist, AstraZeneca, UK |
|
|
Co-Chair |
Dr. Xiaobo Mao, Assistant Professor, The Johns Hopkins University School of Medicine, USA |
|
|
13:30-13:55 |
Title: Development of Acoustic Sample Loading for Mass Spectrometry and Chemistry Applications
Dr. Jonathan Wingfield, Principal Scientist, AstraZeneca, UK |
|
|
13:55-14:20 |
Title: TBD
Dr. Kausik K. Nanda, Pharmaceutical Scientist, Merck, USA |
|
|
14:20-14:45 |
Title: Cytokinin Derivatives, Their Antisenescent Activity, UVA and UVB Photoprotectivity and Prevention of Oxidative Stress
Dr. Lucie Plíhalová, Associate Professor, Palacký University in Olomouc, Czech Republic |
|
|
14:45-15:10 |
Title: Molecular Mechanism of Pathologic Prion-like Proteins Transmission and Neurotoxicity
Dr. Xiaobo Mao, Assistant Professor, The Johns Hopkins University School of Medicine, USA |
|
|
15:10-15:30 |
Coffee Break |
|
|
15:30-15:55 |
Speech Opportunity Available |
|
|
15:55-16:20 |
Title: Development of Radiolabelled Glucosamine and a Core-peptide for Diagnostic Imaging of Arthritis
Dr. Vijay Kumar, Professor, University of Sydney, Australia |
|
|
16:20-16:45 |
Title: New Spiro Compounds and DNA End-joining Inhibition
Dr. K. S. Rangappa, Professor, University of Mysore, India
|
|
|
16:45-17:10 |
Title: Discovery of Hsp70-Bim Complex as a New Drug Target for CML by Using Activity-based Probes
Dr. Ting Song, Associate Professor, Dalian University of Technology, China |
|
|
|
|
Day 2: October 29, 2022 (Saturday)
Forum 4-2: Drug Formulation and Drug Delivery
Time: 08:30-12:10, October 29, 2022 (Saturday); Place: Osaka, Japan |
|
|
|
Call for Chair |
|
|
Co-Chair |
Call for Co-Chair |
|
|
08:30-08:55 |
Title: From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs)
Dr. Thurston David, Professor, King's College London, UK |
|
|
08:55-09:20 |
Title: Spray- Freeze Drying as a New Platform for the Formulation of Precision Medicine
Dr. Hans Leuenberger, Professor, University of Basel, Switzerland |
|
|
09:20-09:45 |
Speech Opportunity Available
|
|
|
09:45-10:10 |
Title: Phospholipid Ether Monomers as Targeted Drug Delivery Vehicles for Cancer
Dr. Jarrod Longcor, Chief Business Officer, Cellectar Biosciences, USA |
|
|
10:10-10:30 |
Speech Opportunity Available
|
|
|
10:30-10:55 |
Title: Plant Virus Nanoparticles to Improve Global Health
Dr. Kathleen Laura Hefferon, Post Doctoral Associate, Cornell University, USA |
|
|
10:55-11:20 |
Title: Stable Injectable Formulation for Sustained Release Delivery of Leuprolide for the Treatment of Advanced Prostate Cancer
Dr. Yuhua Li, Vice President, Foresee Pharmaceuticals, Inc, Taiwan |
|
|
11:20-11:45 |
Title: Antitumor Effects of Fisetin and Fisetin Micelles on Ovarian Cancer in Vitro and in Vivo
Dr. Xue Xiao, West China Medical College of Sichuan University, China |
|
|
11:45-12:10 |
Title: Advances in Multiple Myeloma Therapy during Two Past Decades
Dr. Ivan Spicka, Assistant Professor, Charles University and General Teaching Hospital, Czech Republic |
|
|
Day 3: October 30, 2022 (Sunday)
Forum 4-3: Drug Design and Synthesis
Time: 08:30-12:10, October 30, 2022 (Sunday); Place: Osaka, Japan |
|
|
|
Call for Chair |
|
|
Co-Chair |
Call for Co-Chair |
|
|
08:30-08:55 |
Speech Opportunity Available |
|
|
08:55-09:20 |
Speech Opportunity Available |
|
|
09:20-09:45 |
Title: TBD
Dr. Pascale Gauthier, Pharmacist, University of Clermont Auvergne, France |
|
|
09:45-10:10 |
Title: Recent Discoveries in HIV-1 Reverse Transcriptase Inhibitors
Dr. Shuang-Xi Gu, Professor, Wuhan Institute of Technology, China |
|
|
10:10-10:30 |
Coffee Break |
|
|
10:30-10:55 |
Speech Opportunity Available |
|
|
10:55-11:20 |
Title: Design of Biologically Active Coordination Compounds with Pyromucic Acid
Dr. Irina Lutsenko, Assistant professor, N.S. Kurnakov Institute of General and Inorganic Chemistry, Russia |
|
|
11:20-11:45 |
Title: Tuning Anticancer Function of Small Molecule Drugs Through Aptamer Modification
Dr. Xue-Qiang Wang, Professor, Hunan University, China |
|
|
11:45-12:10 |
Title: Study of The Target Delivery Process of Peptide Modified Liposomes to Solid Tumors
Dr. Hailing Tang, Associate Professor, Guangxi University of Chinese Medicine, China |
|
|
|
